Clinical Trials on Triple Negative Breast Cancer Patients
Total 12193 results
-
Institut Claudius RegaudCompletedTriple Negative Breast CancerFrance
-
George Washington UniversityWithdrawnTriple Negative Breast CancerUnited States
-
Fudan UniversityActive, not recruitingTriple Negative Breast CancerChina
-
Hoffmann-La RocheCompletedTriple Negative Breast CancerUnited States, Korea, Republic of, Belgium, Canada, Germany, United Kingdom, Argentina, Australia, Brazil, Finland, France, Greece, Hungary, Poland, Slovenia, Spain, Taiwan, Turkey, Japan, Singapore, Colombia, Bosnia and Herzegovina, Guatema... and more
-
Universidad Nacional de ColombiaFundación Salud de los AndesCompletedBreast Cancer | Triple Negative Breast CancerColombia
-
Gilead SciencesCompletedBreast CancerUnited States, Canada, Spain, France, Belgium, United Kingdom, Germany
-
Hoffmann-La RocheCompletedBreast CancerFrance, United States, Spain, United Kingdom, Australia
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; ExelixisCompletedBreast CancerUnited States
-
Dana-Farber Cancer InstituteCompleted
-
Jenny C. Chang, MDThe Methodist Hospital Research InstituteCompletedBreast Cancer | Triple Negative Breast CancerUnited States
-
AbbVieNSABP Foundation Inc; German Breast Group; US Oncology Research; Grupo Espanol...CompletedTriple Negative Breast CancerUnited States, Australia, Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom
-
Fudan UniversityUnknown
-
The University of Texas Health Science Center at...Completed
-
Icahn School of Medicine at Mount SinaiChampions OncologyCompletedTriple Negative Breast CancerUnited States
-
Hoosier Cancer Research NetworkClovis Oncology, Inc.CompletedBreast CancerUnited States
-
The Christie NHS Foundation TrustUniversity of ManchesterWithdrawn
-
Fudan UniversityUnknownTriple Negative Breast CancerChina
-
Zhejiang Cancer HospitalUnknownBreast Cancer | Breast Neoplasms | Breast Diseases
-
Tianjin Medical University Cancer Institute and...UnknownTriple Negative Breast CancerChina
-
Columbia UniversityAstellas Pharma Inc; Susan G. Komen Breast Cancer FoundationCompleted
-
Novartis PharmaceuticalsCompletedBreast CancerSpain, United Kingdom, Taiwan, Australia, Russian Federation, Germany, Korea, Republic of, Ireland, United States, Italy, Brazil, Czech Republic
-
SCRI Development Innovations, LLCPfizerCompletedBreast CancerUnited States
-
Washington University School of MedicineTerminatedBreast CancerUnited States
-
University of ChicagoWithdrawn
-
Fudan UniversityUnknown
-
Cancer Institute and Hospital, Chinese Academy...UnknownTriple Negative Breast CancerChina
-
Western Regional Medical CenterWithdrawnMetastatic Non-Small Cell Lung Cancer | Metastatic Colon Cancer | Metastatic Triple Negative Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCedars-Sinai Medical CenterCompletedLocally Recurrent/Metastatic Triple Negative Breast CancerUnited States
-
Massachusetts General HospitalTesaro, Inc.RecruitingTriple Negative Breast Cancer | Residual DiseaseUnited States
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma Inc; Medivation, Inc.Active, not recruitingBreast Cancer | Triple Negative Breast Cancer | Early StageUnited States
-
Fudan UniversityTerminated
-
Eisai Co., Ltd.CompletedBreast Cancer | Breast Tumors | Triple Negative Breast Cancer | Cancer of Breast | HER2-Negative Breast CancerChina
-
Kathy MillerGenentech, Inc.RecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | Estrogen-receptor-low Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
ConcrRoyal Marsden NHS Foundation Trust; Institute of Cancer Research, United Kingdom and other collaboratorsEnrolling by invitationTriple Negative Breast Cancer | Cancer, Breast | Early-stage Breast CancerUnited Kingdom
-
The Methodist Hospital Research InstituteNovartis PharmaceuticalsRecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Metaplastic Breast CarcinomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterBellicum PharmaceuticalsNot yet recruitingBreast Cancer | Triple Negative Breast Cancer | Relapse | Resistant CancerUnited States
-
Centre Francois BaclesseRecruiting
-
Kari WisinskiPfizer; Celcuity IncActive, not recruitingTNBC - Triple-Negative Breast CancerUnited States
-
Ruijin HospitalRecruitingBreast Cancer | Triple Negative Breast Cancer | HER2-positive Breast CancerChina
-
UNC Lineberger Comprehensive Cancer CenterIncyte CorporationWithdrawnBreast Cancer | Breast Neoplasms | Triple Negative Breast Cancer | HER2-positive Breast Cancer
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedBreast CancerUnited States
-
The Methodist Hospital Research InstituteMerck Sharp & Dohme LLCSuspendedTriple Negative Breast Cancer | Anthracycline-refractory TNBCUnited States
-
Pennington Biomedical Research CenterRecruitingBreast NeoplasmsUnited States
-
Yale UniversityCompletedBreast NeoplasmsUnited States
-
Xiang ZhangMirati Therapeutics Inc.TerminatedBreast Neoplasms | Triple Negative Breast Cancer | Breast Cancer Stage IV | Breast Cancer MetastaticUnited States
-
Miguel Martín JiménezUNC Lineberger Comprehensive Cancer Center; Hospital Universitario Ramon y... and other collaboratorsActive, not recruitingBreast Cancer | Breast Cancer Stage II-IIISpain
-
Jo ChienMerck Sharp & Dohme LLCCompletedTriple Negative Breast Cancer | Advanced or Metastatic Breast CancerUnited States
-
University of Colorado, DenverCompletedMetastatic Breast Cancer | Solid TumorsUnited States
-
US Oncology ResearchTranslational Drug Development; Life Technologies, Inc.CompletedMetastatic Breast Cancer | Triple Negative Breast CancerUnited States